Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

584
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
584
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

716
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
716
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

414
Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
414
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

1.2K
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
1.2K
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

506
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
506

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Post-Market Analysis of the Xenios Console With the Xlung Tubing Kit 230 for Extracorporeal Membrane Oxygenation After Cardiac Surgery.

Artificial organs·2026
Same author

Left ventricular recovery and outcomes in patients with a durable left ventricular assist device: the EUROMACS registry.

European heart journal·2026
Same author

Near-zero Ischemia After Prolonged Warm Ischemic Time: Beating-heart DCD Heart Transplantation Following Thoracoabdominal Normothermic Regional Perfusion.

Transplantation·2026
Same author

The many facets of cardiopulmonary complications in sickle cell disease.

Seminars in hematology·2026
Same author

Outcome After Surgery for Type A Intramural Hematoma.

Journal of cardiovascular development and disease·2026
Same author

Vanishing Aortic Valve Cusp: A Rare Case of Aortic Valve Insufficiency in a Durable Left Ventricular Assist Device Recipient After Micro-Axial Flow Pump Support.

Artificial organs·2026

相关实验视频

Updated: Mar 17, 2026

Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device
07:41

Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device

Published on: July 20, 2022

2.5K

心脏切除术后急性右心室衰竭的体外生命支持:一个回顾性观察多中心研究.

Giacomo Bianchi1, Alvaro Perazzo2, Silvia Mariani3

  • 1Ospedale del Cuore Fondazione Toscana "G. Monasterio", Massa, Italy.

The Annals of thoracic surgery
|March 16, 2026
PubMed
概括

心脏手术后急性右心室衰竭 (aRVF) 的体外生命支持 (ECLS) 提出了挑战. 然而,aRVF患者的存活率与其他心脏切除术后症状患者的存活率相似.

更多相关视频

Transthoracic Echocardiography to Assess Post-Resuscitation Left Ventricular Dysfunction After Acute Myocardial Infarction and Cardiac Arrest in Pigs
08:19

Transthoracic Echocardiography to Assess Post-Resuscitation Left Ventricular Dysfunction After Acute Myocardial Infarction and Cardiac Arrest in Pigs

Published on: July 12, 2022

3.7K
Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
07:39

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Published on: August 16, 2021

4.2K

相关实验视频

Last Updated: Mar 17, 2026

Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device
07:41

Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device

Published on: July 20, 2022

2.5K
Transthoracic Echocardiography to Assess Post-Resuscitation Left Ventricular Dysfunction After Acute Myocardial Infarction and Cardiac Arrest in Pigs
08:19

Transthoracic Echocardiography to Assess Post-Resuscitation Left Ventricular Dysfunction After Acute Myocardial Infarction and Cardiac Arrest in Pigs

Published on: July 12, 2022

3.7K
Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
07:39

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Published on: August 16, 2021

4.2K

科学领域:

  • 心脏病学 心脏病学
  • 心脏外科手术 心脏外科手术
  • 临界护理医学 临界护理医学

背景情况:

  • 心脏切除术后急性右心室衰竭 (aRVF) 是一个重大的临床挑战.
  • 它通常需要先进的干预措施,如体外生命支持 (ECLS).

研究的目的:

  • 评估需要ECLS进行心脏切除术后的成年患者的结局.
  • 为了将这些结果与由于其他心脏切割术后原因需要ECLS的患者进行比较.

主要方法:

  • 进行了一项多中心的国际回顾性研究.
  • 分析了2000年1月至2020年12月的患者数据.
  • 在aRVF和其他指示组之间比较了特征和住院死亡率.

主要成果:

  • 在2010年的患者中,有12%患有aRVF;他们在手术前表现出更高的右侧心脏功能障碍.
  • aRVF患者需要更长时间的ECLS支持和ICU停留,有更多的并发症,如出血和持续的右心力衰竭.
  • 住院和长期生存率在aRVF和其他适应症组之间是可比的 (59%与61%对比).

结论:

  • 需要ECLS用于心脏切除术后aRVF的患者面临更高的手术前风险和复杂的临床疗程.
  • 尽管存在这些挑战,但存活结果与其他心脏切割术后ECLS指示的患者相似.